{"id":395330,"date":"2021-12-05T17:09:14","date_gmt":"2021-12-05T20:09:14","guid":{"rendered":"https:\/\/www.ip.gov.py\/ip\/?p=395330"},"modified":"2021-12-05T17:09:14","modified_gmt":"2021-12-05T20:09:14","slug":"israel-estudia-aplicar-una-cuarta-dosis-a-personas-con-inmunodeficiencias","status":"publish","type":"post","link":"https:\/\/www.ip.gov.py\/ip\/2021\/12\/05\/israel-estudia-aplicar-una-cuarta-dosis-a-personas-con-inmunodeficiencias\/","title":{"rendered":"Israel estudia aplicar una cuarta dosis a personas con inmunodeficiencias"},"content":{"rendered":"<p style=\"text-align: justify;\"><em><strong>Tel Aviv.-<\/strong> <\/em>El gobierno de Israel eval\u00faa autorizar el suministro de una cuarta dosis de la vacuna contra el coronavirus para reforzar a la poblaci\u00f3n con inmunodeficiencias en momentos en que la variante \u00f3micron contin\u00faa en expansi\u00f3n, inform\u00f3 hoy la prensa local.<!--more--><\/p>\n<p style=\"text-align: justify;\">Las autoridades sanitarias debatir\u00e1n los pros y contras de la aplicaci\u00f3n de una cuarta dosis de la vacuna anticovid a personas de mayor riesgo debido a la propagaci\u00f3n de la nueva variante \u00f3micron, detectada por primera vez en \u00c1frica, informaron la televisora israel\u00ed Channel 12 y la agencia de noticias Sputnik.<\/p>\n<p style=\"text-align: justify;\">Se prev\u00e9 que los funcionarios de Salud den a conocer la decisi\u00f3n a fines de esta semana.<\/p>\n<p style=\"text-align: justify;\">En tanto, Israel aplic\u00f3 la tercera dosis de la vacuna contra el coronavirus desde julio \u00faltimo, en particular a quienes tienen sistemas inmunitarios en riesgo, como las personas que son sometidas a tratamientos contra el c\u00e1ncer.<\/p>\n<p style=\"text-align: justify;\">Varios estudios realizados en meses anteriores demostraron que ciertas categor\u00edas de pacientes con un sistema inmunol\u00f3gico debilitado, como los receptores de trasplantes, tienen muchas menos probabilidades de desarrollar anticuerpos despu\u00e9s de dos dosis que la poblaci\u00f3n general.<\/p>\n<p style=\"text-align: justify;\">Adem\u00e1s de Israel, el Reino Unido tambi\u00e9n estudia la administraci\u00f3n de una cuarta dosis de la vacuna para poblaci\u00f3n con inmunodeficiencias.T\u00e9lam<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Tel Aviv.- El gobierno de Israel eval\u00faa autorizar el suministro de una cuarta dosis de la vacuna contra el coronavirus para reforzar a la poblaci\u00f3n con inmunodeficiencias en momentos en que la variante \u00f3micron contin\u00faa en expansi\u00f3n, inform\u00f3 hoy la prensa local.<\/p>\n","protected":false},"author":23,"featured_media":377996,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"footnotes":""},"categories":[5],"tags":[432,412,9837],"class_list":{"0":"post-395330","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-internacionales","8":"tag-israel","9":"tag-vacunacion","10":"tag-variante-omicron"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Israel estudia aplicar una cuarta dosis a personas con inmunodeficiencias - .::Agencia IP::.<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.ip.gov.py\/ip\/2021\/12\/05\/israel-estudia-aplicar-una-cuarta-dosis-a-personas-con-inmunodeficiencias\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Israel estudia aplicar una cuarta dosis a personas con inmunodeficiencias - .::Agencia IP::.\" \/>\n<meta property=\"og:description\" content=\"Tel Aviv.- El gobierno de Israel eval\u00faa autorizar el suministro de una cuarta dosis de la vacuna contra el coronavirus para reforzar a la poblaci\u00f3n con inmunodeficiencias en momentos en que la variante \u00f3micron contin\u00faa en expansi\u00f3n, inform\u00f3 hoy la prensa local.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.ip.gov.py\/ip\/2021\/12\/05\/israel-estudia-aplicar-una-cuarta-dosis-a-personas-con-inmunodeficiencias\/\" \/>\n<meta property=\"og:site_name\" content=\".::Agencia IP::.\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/IPParaguay\/\" \/>\n<meta property=\"article:published_time\" content=\"2021-12-05T20:09:14+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.ip.gov.py\/ip\/wp-content\/uploads\/2021\/08\/Israel.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1004\" \/>\n\t<meta property=\"og:image:height\" content=\"565\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Noelia Ferreira\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@IPParaguay\" \/>\n<meta name=\"twitter:site\" content=\"@IPParaguay\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"Noelia Ferreira\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minuto\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/2021\\\/12\\\/05\\\/israel-estudia-aplicar-una-cuarta-dosis-a-personas-con-inmunodeficiencias\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/2021\\\/12\\\/05\\\/israel-estudia-aplicar-una-cuarta-dosis-a-personas-con-inmunodeficiencias\\\/\"},\"author\":{\"name\":\"Noelia Ferreira\",\"@id\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/#\\\/schema\\\/person\\\/791af27a9219bdbf9064abb776bb41c2\"},\"headline\":\"Israel estudia aplicar una cuarta dosis a personas con inmunodeficiencias\",\"datePublished\":\"2021-12-05T20:09:14+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/2021\\\/12\\\/05\\\/israel-estudia-aplicar-una-cuarta-dosis-a-personas-con-inmunodeficiencias\\\/\"},\"wordCount\":233,\"publisher\":{\"@id\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/2021\\\/12\\\/05\\\/israel-estudia-aplicar-una-cuarta-dosis-a-personas-con-inmunodeficiencias\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/wp-content\\\/uploads\\\/2021\\\/08\\\/Israel.jpg\",\"keywords\":[\"Israel\",\"Vacunaci\u00f3n\",\"Variante Omicr\u00f3n\"],\"articleSection\":[\"Internacionales\"],\"inLanguage\":\"es\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/2021\\\/12\\\/05\\\/israel-estudia-aplicar-una-cuarta-dosis-a-personas-con-inmunodeficiencias\\\/\",\"url\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/2021\\\/12\\\/05\\\/israel-estudia-aplicar-una-cuarta-dosis-a-personas-con-inmunodeficiencias\\\/\",\"name\":\"Israel estudia aplicar una cuarta dosis a personas con inmunodeficiencias - .::Agencia IP::.\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/2021\\\/12\\\/05\\\/israel-estudia-aplicar-una-cuarta-dosis-a-personas-con-inmunodeficiencias\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/2021\\\/12\\\/05\\\/israel-estudia-aplicar-una-cuarta-dosis-a-personas-con-inmunodeficiencias\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/wp-content\\\/uploads\\\/2021\\\/08\\\/Israel.jpg\",\"datePublished\":\"2021-12-05T20:09:14+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/2021\\\/12\\\/05\\\/israel-estudia-aplicar-una-cuarta-dosis-a-personas-con-inmunodeficiencias\\\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/2021\\\/12\\\/05\\\/israel-estudia-aplicar-una-cuarta-dosis-a-personas-con-inmunodeficiencias\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/2021\\\/12\\\/05\\\/israel-estudia-aplicar-una-cuarta-dosis-a-personas-con-inmunodeficiencias\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/wp-content\\\/uploads\\\/2021\\\/08\\\/Israel.jpg\",\"contentUrl\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/wp-content\\\/uploads\\\/2021\\\/08\\\/Israel.jpg\",\"width\":1004,\"height\":565,\"caption\":\"T\u00e9lam\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/2021\\\/12\\\/05\\\/israel-estudia-aplicar-una-cuarta-dosis-a-personas-con-inmunodeficiencias\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Portada\",\"item\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Israel estudia aplicar una cuarta dosis a personas con inmunodeficiencias\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/#website\",\"url\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/\",\"name\":\".::Agencia IP::.\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/#organization\",\"name\":\"Agencia IP\",\"url\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/wp-content\\\/uploads\\\/2018\\\/01\\\/Agencia-IP.jpg\",\"contentUrl\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/wp-content\\\/uploads\\\/2018\\\/01\\\/Agencia-IP.jpg\",\"width\":150,\"height\":150,\"caption\":\"Agencia IP\"},\"image\":{\"@id\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/IPParaguay\\\/\",\"https:\\\/\\\/x.com\\\/IPParaguay\",\"https:\\\/\\\/www.instagram.com\\\/IPParaguay\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/#\\\/schema\\\/person\\\/791af27a9219bdbf9064abb776bb41c2\",\"name\":\"Noelia Ferreira\",\"sameAs\":[\"http:\\\/\\\/www.ip.gov.py\"],\"url\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/author\\\/nferreira\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Israel estudia aplicar una cuarta dosis a personas con inmunodeficiencias - .::Agencia IP::.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.ip.gov.py\/ip\/2021\/12\/05\/israel-estudia-aplicar-una-cuarta-dosis-a-personas-con-inmunodeficiencias\/","og_locale":"es_ES","og_type":"article","og_title":"Israel estudia aplicar una cuarta dosis a personas con inmunodeficiencias - .::Agencia IP::.","og_description":"Tel Aviv.- El gobierno de Israel eval\u00faa autorizar el suministro de una cuarta dosis de la vacuna contra el coronavirus para reforzar a la poblaci\u00f3n con inmunodeficiencias en momentos en que la variante \u00f3micron contin\u00faa en expansi\u00f3n, inform\u00f3 hoy la prensa local.","og_url":"https:\/\/www.ip.gov.py\/ip\/2021\/12\/05\/israel-estudia-aplicar-una-cuarta-dosis-a-personas-con-inmunodeficiencias\/","og_site_name":".::Agencia IP::.","article_publisher":"https:\/\/www.facebook.com\/IPParaguay\/","article_published_time":"2021-12-05T20:09:14+00:00","og_image":[{"width":1004,"height":565,"url":"https:\/\/www.ip.gov.py\/ip\/wp-content\/uploads\/2021\/08\/Israel.jpg","type":"image\/jpeg"}],"author":"Noelia Ferreira","twitter_card":"summary_large_image","twitter_creator":"@IPParaguay","twitter_site":"@IPParaguay","twitter_misc":{"Escrito por":"Noelia Ferreira","Tiempo de lectura":"1 minuto"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.ip.gov.py\/ip\/2021\/12\/05\/israel-estudia-aplicar-una-cuarta-dosis-a-personas-con-inmunodeficiencias\/#article","isPartOf":{"@id":"https:\/\/www.ip.gov.py\/ip\/2021\/12\/05\/israel-estudia-aplicar-una-cuarta-dosis-a-personas-con-inmunodeficiencias\/"},"author":{"name":"Noelia Ferreira","@id":"https:\/\/www.ip.gov.py\/ip\/#\/schema\/person\/791af27a9219bdbf9064abb776bb41c2"},"headline":"Israel estudia aplicar una cuarta dosis a personas con inmunodeficiencias","datePublished":"2021-12-05T20:09:14+00:00","mainEntityOfPage":{"@id":"https:\/\/www.ip.gov.py\/ip\/2021\/12\/05\/israel-estudia-aplicar-una-cuarta-dosis-a-personas-con-inmunodeficiencias\/"},"wordCount":233,"publisher":{"@id":"https:\/\/www.ip.gov.py\/ip\/#organization"},"image":{"@id":"https:\/\/www.ip.gov.py\/ip\/2021\/12\/05\/israel-estudia-aplicar-una-cuarta-dosis-a-personas-con-inmunodeficiencias\/#primaryimage"},"thumbnailUrl":"https:\/\/www.ip.gov.py\/ip\/wp-content\/uploads\/2021\/08\/Israel.jpg","keywords":["Israel","Vacunaci\u00f3n","Variante Omicr\u00f3n"],"articleSection":["Internacionales"],"inLanguage":"es"},{"@type":"WebPage","@id":"https:\/\/www.ip.gov.py\/ip\/2021\/12\/05\/israel-estudia-aplicar-una-cuarta-dosis-a-personas-con-inmunodeficiencias\/","url":"https:\/\/www.ip.gov.py\/ip\/2021\/12\/05\/israel-estudia-aplicar-una-cuarta-dosis-a-personas-con-inmunodeficiencias\/","name":"Israel estudia aplicar una cuarta dosis a personas con inmunodeficiencias - .::Agencia IP::.","isPartOf":{"@id":"https:\/\/www.ip.gov.py\/ip\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.ip.gov.py\/ip\/2021\/12\/05\/israel-estudia-aplicar-una-cuarta-dosis-a-personas-con-inmunodeficiencias\/#primaryimage"},"image":{"@id":"https:\/\/www.ip.gov.py\/ip\/2021\/12\/05\/israel-estudia-aplicar-una-cuarta-dosis-a-personas-con-inmunodeficiencias\/#primaryimage"},"thumbnailUrl":"https:\/\/www.ip.gov.py\/ip\/wp-content\/uploads\/2021\/08\/Israel.jpg","datePublished":"2021-12-05T20:09:14+00:00","breadcrumb":{"@id":"https:\/\/www.ip.gov.py\/ip\/2021\/12\/05\/israel-estudia-aplicar-una-cuarta-dosis-a-personas-con-inmunodeficiencias\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.ip.gov.py\/ip\/2021\/12\/05\/israel-estudia-aplicar-una-cuarta-dosis-a-personas-con-inmunodeficiencias\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.ip.gov.py\/ip\/2021\/12\/05\/israel-estudia-aplicar-una-cuarta-dosis-a-personas-con-inmunodeficiencias\/#primaryimage","url":"https:\/\/www.ip.gov.py\/ip\/wp-content\/uploads\/2021\/08\/Israel.jpg","contentUrl":"https:\/\/www.ip.gov.py\/ip\/wp-content\/uploads\/2021\/08\/Israel.jpg","width":1004,"height":565,"caption":"T\u00e9lam"},{"@type":"BreadcrumbList","@id":"https:\/\/www.ip.gov.py\/ip\/2021\/12\/05\/israel-estudia-aplicar-una-cuarta-dosis-a-personas-con-inmunodeficiencias\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Portada","item":"https:\/\/www.ip.gov.py\/ip\/"},{"@type":"ListItem","position":2,"name":"Israel estudia aplicar una cuarta dosis a personas con inmunodeficiencias"}]},{"@type":"WebSite","@id":"https:\/\/www.ip.gov.py\/ip\/#website","url":"https:\/\/www.ip.gov.py\/ip\/","name":".::Agencia IP::.","description":"","publisher":{"@id":"https:\/\/www.ip.gov.py\/ip\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.ip.gov.py\/ip\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/www.ip.gov.py\/ip\/#organization","name":"Agencia IP","url":"https:\/\/www.ip.gov.py\/ip\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.ip.gov.py\/ip\/#\/schema\/logo\/image\/","url":"https:\/\/www.ip.gov.py\/ip\/wp-content\/uploads\/2018\/01\/Agencia-IP.jpg","contentUrl":"https:\/\/www.ip.gov.py\/ip\/wp-content\/uploads\/2018\/01\/Agencia-IP.jpg","width":150,"height":150,"caption":"Agencia IP"},"image":{"@id":"https:\/\/www.ip.gov.py\/ip\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/IPParaguay\/","https:\/\/x.com\/IPParaguay","https:\/\/www.instagram.com\/IPParaguay"]},{"@type":"Person","@id":"https:\/\/www.ip.gov.py\/ip\/#\/schema\/person\/791af27a9219bdbf9064abb776bb41c2","name":"Noelia Ferreira","sameAs":["http:\/\/www.ip.gov.py"],"url":"https:\/\/www.ip.gov.py\/ip\/author\/nferreira\/"}]}},"_links":{"self":[{"href":"https:\/\/www.ip.gov.py\/ip\/wp-json\/wp\/v2\/posts\/395330","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ip.gov.py\/ip\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.ip.gov.py\/ip\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.ip.gov.py\/ip\/wp-json\/wp\/v2\/users\/23"}],"replies":[{"embeddable":true,"href":"https:\/\/www.ip.gov.py\/ip\/wp-json\/wp\/v2\/comments?post=395330"}],"version-history":[{"count":0,"href":"https:\/\/www.ip.gov.py\/ip\/wp-json\/wp\/v2\/posts\/395330\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.ip.gov.py\/ip\/wp-json\/wp\/v2\/media\/377996"}],"wp:attachment":[{"href":"https:\/\/www.ip.gov.py\/ip\/wp-json\/wp\/v2\/media?parent=395330"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.ip.gov.py\/ip\/wp-json\/wp\/v2\/categories?post=395330"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.ip.gov.py\/ip\/wp-json\/wp\/v2\/tags?post=395330"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}